8-K//Current report
Apimeds Pharmaceuticals US, Inc. 8-K
Accession 0001213900-25-099553
$APUSCIK 0001894525operating
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:15 PM ET
Size
195.1 KB
Accession
0001213900-25-099553
Documents
- 8-Kea0261543-8k_apimeds.htmPrimary
CURRENT REPORT
- EX-3.1ea026154301ex3-1_apimeds.htm
FIRST AMENDMENT TO BYLAWS DATED OCTOBER 15, 2025
- EX-101.SCHapus-20251015.xsd
XBRL SCHEMA FILE
- EX-101.LABapus-20251015_lab.xml
XBRL LABEL FILE
- EX-101.PREapus-20251015_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-099553-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0261543-8k_apimeds_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Apimeds Pharmaceuticals US, Inc.
CIK 0001894525
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001894525
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:15 PM ET
- Size
- 195.1 KB